- $71.34m
- $102.31m
- $92.07m
- 45
- 91
- 19
- 51
Annual income statement for Emeren, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 73.5 | 79.7 | 61.3 | 106 | 92.1 |
| Cost of Revenue | |||||
| Gross Profit | 16.7 | 31.4 | 15.3 | 25 | 24.1 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 66.7 | 67 | 63.9 | 114 | 92.6 |
| Operating Profit | 6.78 | 12.7 | -2.63 | -8.66 | -0.504 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 2.32 | 7.39 | -2.63 | -2.9 | -9.59 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 2.16 | 6.61 | -4.55 | -5.43 | -11.6 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 2.78 | 6.86 | -4.67 | -3.19 | -12.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 2.78 | 6.86 | -4.67 | -3.19 | -12.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.008 | 0.012 | -0.007 | -0.004 | -0.024 |